Company

Qihan Biotech

Rocket Ship Rating

Rocket Ship Rating: 75 out of 100

Biotech & therapeutics

Business model: B2B

qihanbio.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding. We apply these tools in both human stem cells and animal germline cells to deliver novel immune-privileged cell and organ therapies.

Relationships

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.